We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

131 hedge funds and large institutions have $645M invested in Arena Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 31 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 31

3% more capital invested

Capital invested by funds: $629M → $645M (+$15.9M)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 134131 (-3)

46% less call options, than puts

Call options by funds: $29.8M | Put options by funds: $54.7M

Holders
131
Holders Change
-3
Holders Change %
-2.24%
% of All Funds
3.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
48
Reduced
31
Closed
22
Calls
$29.8M
Puts
$54.7M
Net Calls
-$24.9M
Net Calls Change
+$1.98M
Name Holding Trade Value Shares
Change
Change in
Stake
AIG
26
American International Group
New York
$3.41M +$10.3K +155 +0.3%
AllianceBernstein
27
AllianceBernstein
Tennessee
$2.94M +$356K +5,373 +13%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$2.49M +$11.3K +170 +0.4%
ProShare Advisors
29
ProShare Advisors
Maryland
$2.49M +$1.84M +27,670 +232%
PAMU
30
Pictet Asset Management (UK)
United Kingdom
$2.44M +$40.5K +610 +2%
BL
31
Bolton LP
Connecticut
$2.36M +$135K +2,040 +6%
CA
32
Commerzbank Aktiengesellschaft
Germany
$2.29M +$2.42M +36,410 New
CS
33
Credit Suisse
Switzerland
$2.25M -$3.37M -50,856 -59%
GH
34
GAM Holding
Switzerland
$1.8M +$88.5K +1,334 +5%
Allianz Asset Management
35
Allianz Asset Management
Germany
$1.61M
Swiss National Bank
36
Swiss National Bank
Switzerland
$1.54M +$370K +5,570 +30%
Nomura Holdings
37
Nomura Holdings
Japan
$1.41M +$1.06K +16 +0.1%
BG
38
BlackRock Group
United Kingdom
$1.41M +$28.7K +433 +2%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$1.38M -$38K -572 -3%
SM
40
Sabby Management
Florida
$1.36M +$1.43M +21,570 New
USAA
41
United Services Automobile Association
Texas
$1.31M +$47.1K +710 +4%
State Board of Administration of Florida Retirement System
42
State Board of Administration of Florida Retirement System
Florida
$1.25M
SB
43
Suntrust Banks
Georgia
$1.16M +$1.1M +16,612 +879%
PA
44
Profund Advisors
Maryland
$1.14M +$241K +3,628 +25%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$1.13M
CBOA
46
Commonwealth Bank of Australia
Australia
$1.07M -$58.4K -880 -5%
American Century Companies
47
American Century Companies
Missouri
$880K -$2.26M -34,087 -71%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$867K
DekaBank Deutsche Girozentrale
49
DekaBank Deutsche Girozentrale
Germany
$828K +$46.4K +700 +6%
PP
50
PDT Partners
New York
$808K +$851K +12,830 New

ARNA Hedge Fund Activity: Q1 2014 in Review

131 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2014, worth a combined $645M — up 2.5% from $629M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ARNA and 21 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 48 added.

The largest buyer was OppenheimerFunds, adding an estimated $6.63M. The largest seller was Samlyn Capital, exiting entirely with an estimated $21.4M sold.

  • 131 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2014, down from 134 in Q4 2013.
  • Funds reported $645M of Arena Pharmaceuticals Inc stock for Q1 2014, up 2.5% quarter-over-quarter.
  • 21 funds opened new Arena Pharmaceuticals Inc positions in Q1 2014 and 22 closed out, a net change of -1 holder.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2014 was OppenheimerFunds, an estimated $6.63M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2014 was Samlyn Capital, an estimated $21.4M sold.

Based on aggregated 13F filings for Q1 2014.